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1. Introduction 
Consideration indicates that enzyme-immunoassay 
could overcome the serious drawbacks of expense and 
radiation hazard inherent in the radioimmunoassay 
technique [l-4]. Unfortunately despite several efforts 
over the past few years, developed enzyme-immuno- 
assay procedures have not as yet seriously rivalled the 
popular established radioimmunoassay method on 
both counts of sensitivity and specificity. 
The development of a highly sensitive enzyme- 
immunoassay method for measurement of hormones 
such as oestrogens at the sub-picomole level, demands 
a critical choice of high specific activity enzyme [5] 
which has to be stable on chemical modification and 
the measurement of its activity must be simple and 
sensitive. Horse radish peroxidase (EC 1.11 .1.7) which 
appears to satisfy most of these requirements has 
been used for the enzyme immunoassay of oestradiol- 
17p [6-81 . Escherichia coli /3-D-galactoside-galacto- 
hydrolyase (EC 3.2.1.23) also possesses the above 
required properties: however its high specific activity 
makes it superior to peroxidase. Although several 
antigens have been conjugated to this enzyme and 
used in enzyme-immunoassay procedures [9-l 11, as 
yet no enzyme immunoassay method using the 
enzyme for the determination of oestradiol-170 has 
been reported. The preparation and affinity chromato- 
graphy purification procedures of an i?. coli galacto- 
sidase-oestradiol-170 conjugate in [ 121 were shown 
to be of paramount importance for obtaining pure 
enzyme-steroid label for highly sensitive enzyme- 
immunoassay. 
Improvement and simplification of these previous 
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preparation and purification procedures, coupled with 
the use of the double antibody precipitation tech- 
nique and a judicious choice of heterology between 
antiserum and enzyme-steroid conjugation bridge 
[7] has led to the development of a simple highly 
sensitive and highly specific enzyme-immunoassay 
method for oestradiol-170. This method is as simple, 
sensitive and specific as the radioimmunoassay tech- 
nique for this hormone, and possesses the additional 
advantages of lower cost and freedom from radia- 
tion hazard. 
2. Materials and methods 
2.1. Reagents 
[2,4,6,7-3H]Oestradiol-17/3 (spec. act. 8.5 Ci/mM) 
was obtained from the Radiochemical Centre, 
Amersham and non-radioactive steroids from Koch- 
Light, Colnbrook, Bucks. I-Cyclohexyl-3-(2 morpho- 
linoethyl) carbodiimide metho-p-toluene sulphonate 
(CMC) was obtained from Sigma, St Louis, MO; 
Sepharose 4B, DEAE -Sephadex A-50 and Sephadex 
G-25 were obtained from Pharmacia, Uppsala. The 
synthetic substrate o-nitrophenyl-/3-D-galactoside 
(ONP-G) and mercaptoethanol were obtained from 
the British Drug Houses, Poole, Dorset. The hapten 
used for enzyme conjugation, oestradiol-17/3-6x0 
carboxymethyl)-oxime (E,6CMO) was synthesised 
according to [ 131 . Antiserum to oestradiol-I 70 raised 
by oestradiol-170-3 hemisuccinate-BSA was prepared 
according to [ 141. The assay buffer used for both 
enzyme and radioimmunoassay was 0.1 M phosphate 
buffer (pH 7.0) 0.01 M MgCl*, 0.1 M NaCI, 0.1% 
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sodium azide and 0.1% gelatin. Donkey anti-rabbit 
serum was obtained from Burroughs Wellcome, 
Beckenham. An SP6 spectrophotometer @ye Unicam, 
Cambridge) was used for absorptiometric measure- 
ment. 
2.2. ~ep~r~tio~ of the e~~y~~-stero~ ~on~~g~te 
The steps involved in the preparation and the 
purification of the conjugates have been described 
1121. Modi~cations, however, have been introduced 
to these procedures. The first step was to obtain and 
purify O-D-galactosidase from E. c&i. Mutant K12 
3300 cells were cultured and harvested in the normal 
way, and then the cells ruptured on a French press 
machine. The resultant suspension was centrifuged 
to remove insoluble material before subjection to 
40% ammonium sulphate precipitation. The crude 
enzyme was then purified by D~AE-~phadex-A50 
[IS] to a high specific activity to ONP-G substrate 
(350 ~M~mg/min). The enzyme-steroid conjugate 
was prepared using E26CM0. condensation of this 
compound with lysyl groups of the enzyme to form 
a peptide link was effected using the carbodiimide 
CMC. An intermediate of E,6CMO and CMC was 
first formed in 0.2 M phosphate buffer (pH 6.70, 
containing 0.1 M NaCl) by reacting 1 mg E26CM0 
(0.5 mg/ml) with 84 mg CMC added in solid form 
at 10-l 5°C for 30 min. This intermediate was then 
added slowly to 10 mg enzyme (20 mg/ml buffer) 
and the mixture stirred at 4’C for 16 h. This con- 
jugation procedure was milder than the method in 
[ 121 and no loss of specific activity of the enzyme 
occurred during the conjugation step. The enzyme 
conjugate was purified by dialysis, gel-filtration 
and a steroid affinity column step as in f 121. The 
enzyme affinity column step was not needed, since 
as stated the mild conjugation had preserved the 
specific activity of the enzyme. An aliquot of the 
final purified E. co& ~-D-galactosidase-oestradiol-17~ 
conjugate was hydrolysed with acid and the amount 
of 6keto-oestradioLl7fl produced determined by 
radioimmunoassay; this enabled assessment of the 
enzyme/steroid ratio which was found to be 1: 1.7. 
2.3. The enzyme-immunoassay method 
E23HS antiserum, 0.1 ml (dilution 1~3200; 
3.6 X lo-” mol/litre anti-E, activity), 0.1 ml 
enzyme-steroid conjugate (82 ng/ml) and 0.1 ml 
various doses of E2 standard were incubated at 37*C 
for 1 h. The mixture was then allowed to cool for 
20 min, then 0.1 ml donkey anti-rabbit antiserum 
(dilution 1:2S) added. Incubation was continued 
for 16 h at 4°C. The immune precipitate was washed 
twice by the addition of 1 .O ml assay buffer then 
centrifuged at 3000 X g for 20 min in a refrigerated 
centrifuge; the supernatant was then decanted. The 
enzyme activity in the immune precipitates was 
measured by adding 0.2 ml ONP-G substrate 
(0.7 mg/mI in assay buffer containing 0.1 M mercap- 
toethanol) and incubating for 20 min at 37°C in a 
thermostatically-controlled waterbath. The reaction 
was stopped by the addition of 1 ml 1 .O M sodium 
carbonate solution. The amount of hydrolysed sub- 
strate was estimated by measuring A405 nm. 
A radioimmunoassay method was set up using 
exactly the same conditions as above except that the 
enzyme label was replaced by its calculated equivalent 
of 12.7 pg [2,4,6,7-aH]oestradiol-17/3 and the per- 
formance of both immunoassays was compared. 
3. Results 
A comparison between typical enzyme-immuno- 
assay and radioimmunoassay standard curves for Ez 
is shown in fig.1. The results show that under the 
conditions described, the enzyme-immunoassay 
method was slightly more sensitive than radioimmuno- 
assay. The specificity of the respective immunoassay 
techniques was assessed by both the well-established 
technique in f I 61 and by a recently-devised logit -log 
system [ 171. Both methods of assessment made for 
the three related ligands, oestrone (E,), oestriol (E3) 
and oestradiol-17~~ (E+Y) showed that the enzyme- 
immunoassay method tended to be slightly more 
specific than radioimmunoassay. Defining the cross 
reactivity of the standard ligand Ea as 100% for both 
methods, the enzyme-imnlunoassay results were 
Er 0.7%, E3 < O.l%, Ezac 0.4% and for radioimmuno- 
assay were Er I .5%, E3 < 0.1% and E,cu 0.4%. 
Various doses of E, ranging from 50-500 pg were 
added to human male plasma (of known E2 content) 
extracted with ether, and assayed by both immuno- 
assay procedures. Almost identical results were 
obtained from these methods indicating that the 
enzyme-immunoassay technique can be used to 
assay human plasma samples. 
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1:ig.1. Standard curves howing amount (%) bound enzyme 
activity for various oestradiol-17~ doses (B) as a ratio with 
that bound using the enzyme-labellcd conjuptc alone (0,); 
compared with similar results for radioimmunoass3y. (0) 
Radioimmunoassay. (a) Enzyme-radioimmunoassay. 
4. Discussion 
The described oestradiol-170 method involves 
probably the simplest, most sensitive and specific 
enzyme-immunoassay technique yet produced for 
any compound. The high sensitivity of the enzyme- 
immunoassay method can be mainly attributed to 
the use of the high specific activity enLyme and the 
preparation and purification of the low molar ratio 
enzyme-steroid conjugate used as immunoassay label. 
Factors involved in the preparation and purification 
procedures which helped to preserve the enzyme 
activity of the conjugate and therefore the sensitivity 
of the immunoassay are: 
(i) The mild enzyme-steroid conjugation technique 
which did not cause any loss of enzyme activity: 
(ii) The aftinity chromatography purification step. 
which still preserved this activity. 
Again the affinity chromatography step. removed all 
unconjugated enzyme and thus eliminated any back- 
ground enzyme activity which if not removed would 
interfere with enzyme immunoassay by increasing the 
blank, hence lowering the sensitivity. Another factor 
in the enzyme-immunoassay method affecting sensitiv- 
ity is the use of the double antibody precipitation 
separation procedure which unlike solid phase methods 
is not only simple, but the immune precipitate does 
not interfere with enzyme activity. 
Alternative assessment of the I:: coli /3-D-galacto- 
sidase activity by the more sensitive fluorogenic sub- 
strate 4-methyl umbelliferyl/3-D-galactoside was found 
to be too sensitive for the enzynie-immunoassay end- 
point determination. Since the limit of sensitivity of 
any immunoassay method is dictated by the apparent 
equilibrium constant (Kar,J of the heterogenous anti- 
body collection with the antigen or hapten [ 181, this 
means that use of higher- Knpp antiserum should 
enable determination of oestradiol-I 70 at sub-pico- 
gram levels. This is one of the rare occasions when 
the measurement of the labelled tracer has been 
recorded as being too sensitive for immunoassay at 
picogram levels. 
Previous heterologous enzyme-immunoassay 
methods [7] have invariably sacrificed specificity at 
the expense of sensitivity. The heterologous combina- 
tion between the specific E23HS antiserum [ 141 and 
the enzyme--E,6CMO conjugate produced specific 
as well as sensitive enzyme-immunoassay, because 
the O-carboxymethyl-oxime bridge link between 
enzyme and steroid was not antigenically recognised 
by the antiserum. 
The simple automatable calorimetric measurement 
of enzyme activity using a standard laboratory spectro- 
photometer and an inexpensive readily available sub- 
strate makes the enzyme-immunoassay method 
cheaper and possibly simpler than radioimmuno- 
assay. These desirable advantages coupled with the 
fact that the enzyme-immunoassay method is just as 
sensitive and specific as radioimmunoassay methods 
for oestradiol-170 and even possesses a potential 
sensitivity superior to these latter techniques, as well 
as freedom from radiation hazard using an enzyme 
label superior to radioactive labels as regards shelf 
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life; all makes the enzyme immunoassay method 
more than a serious rival to rad~oimmunoassay and 
may become the technique of choice in the future. 
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